Norley, S.

monkey challenge antibody vaccine group preparation virus protection titre immunization iscom protein elisa group b rhesu serum infection rhesus pbmc siv-iscom siv-mdp figure sivmac gpl 20 animal siv-specific table development cell-associated siv wb analysis analysis siv vaccine preparations c 8166 cells dilution immunity vaccine preparations siv-iscom-immunized 6 weeks siv-iscom-immunized monkeys gpl 20-enriched iscoms siv-specific immunity aids res siv-immunized monkeys gpl 20-inhibition elisa cell-associated siv-mdp-immunized monkeys disease immunodeficiency siv-mdp-immunized macaque siv-infected vaccination study 4 weeks 32-inhibition gpl 20- inhibition siv infection hiv -2 infection response stock gp 32-inhibition elisa gp 32-inhibition elisas postchallenge aids vaccine developments immunodeficiency virus infection antigen e e k rhesus macaques figure 3 cranage mv-iscom inhibition elisa siv challenge vaccine protection pharmacia lkb inhibition elisas presence method experiment detection